HealthTech Arkansas, a startup accelerator for early-stage healthcare companies, has announced a new partnership with Kx Advisors, a healthcare strategy consulting firm, to provide support to companies participating in the BioAR Trial accelerator program.
As part of the partnership, companies selected for the BioAR Trial cohort will participate in a virtual seminar on growth strategies presented by Kx Advisors in addition to one-on-one follow-up sessions, according to the announcement.
“We’re very excited to bring the formidable skills and experiences of the Kx team to bear for BioAR Trial cohort companies,” said Jeff Stinson, director of HealthTech Arkansas. “Personalized, high-level advisement on growth strategies is another example of how we add value to early-stage companies developing advanced biotherapeutics.”
“We’re thrilled to collaborate in this partnership with HealthTech Arkansas to support the advancement of innovative biotherapeutics and the hope they provide to patients, families, and their healthcare providers,” said Sean Vander Linde, partner at Kx Advisors. “Among Kx’s strengths is our strategic advice supporting companies with clinical-stage assets. Partnerships such as these allow us to contribute to setting these organizations and their valuable innovations up for success.”
BioAR Trial was created to help biotherapeutics companies in late pre-clinical stages of development bring groundbreaking therapies to market faster, while increasing Arkansans’ access to cutting-edge clinical care and innovative medicines. Applications for the trial are open through Feb. 28, more information and a link to the application can be found here.
READ ALSO: GASTROARKANSAS MOVES LITTLE ROCK MIDTOWN LOCATION
